{
  "trial_id": "NCT03529955",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Must understand the risks and the benefits/purpose of the study and provide signed and dated informed consent.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Must be 18 years at time of signing the informed consent form.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Willing to participate in all required evaluations and procedures in the study including the ability to swallow pills without difficulty.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Increasing or changing dose of topical therapy within 14 days of study day 0 (including but not limited to topical corticosteroids, tacrolimus, pimecrolimus).",
      "label": "triggers"
    },
    {
      "criterion": "Pregnant or breastfeeding.",
      "label": "triggers"
    }
  ],
  "notes": "The patient is a 16-year-old girl with Hashimoto disease. She does not meet the age requirement for informed consent and is pregnant.",
  "_meta": {
    "topic_id": "66",
    "trial_id": "NCT03529955",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}